Business
Starpharma pauses UK sales of COVID spray after regulator’s queries – Sydney Morning Herald
The Melbourne biotech has paused sales of its coronavirus fighting product after the UK medicines watchdog wrote to its distributor…
Australian biotech firm Starpharma has paused the sales of its coronavirus-fighting nasal spray in the United Kingdom after the British medicines regulator questioned promotional claims made about the product.
The ASX-listed firm applied the same active…
Continue Reading
-
Noosa News15 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General19 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News24 hours agoTributes flow for Geham wife and mother after husband charged with murder
-
Noosa News15 hours agoHow to find out your TikTok personality – and become a ‘citizen scientist’